PEPTO BISMOL EXTRA INSTACOOL 35.2 MG
BISMUTH SUBSALICYLATE : 35.2 MG · DIN 02556987 · PROCTER & GAMBLE INC
Health Canada status: APPROVED
What is PEPTO BISMOL EXTRA INSTACOOL?
PEPTO BISMOL EXTRA INSTACOOL 35.2 MG contains BISMUTH SUBSALICYLATE : 35.2 MG. It is listed in the Health Canada Drug Product Database under DIN 02556987, held by PROCTER & GAMBLE INC, supplied as SUSPENSION for ORAL administration. Health Canada currently lists it as approved, status dated 15-Apr-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02556987 |
|---|---|
| Brand name | PEPTO BISMOL EXTRA INSTACOOL |
| Generic / active ingredient | BISMUTH SUBSALICYLATE : 35.2 MG |
| Manufacturer | PROCTER & GAMBLE INC |
| Strength | 35.2 MG |
| Dosage form | SUSPENSION |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A07BB BISMUTH PREPARATIONS |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 15-Apr-2025 |
What can be used instead?
Other Canadian products sharing ATC code A07BB BISMUTH PREPARATIONS. 12 of 55 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BISMUTH CAPLETS | 262 MG | TABLET | JUNO OTC INC | MARKETED | DIN 02457121 |
| BISMUTH SUBSALICYLATE CAPLETS | 262 MG | TABLET | GUARDIAN DRUG COMPANY INC | MARKETED | DIN 02326582 |
| BISMUTH SUBSALICYLATE SUSPENSION | 17.5 MG | SUSPENSION | GUARDIAN DRUG COMPANY INC | MARKETED | DIN 02313162 |
| EXTRA STRENGTH BISMUTH | 35.2 MG | SUSPENSION | JUNO OTC INC | MARKETED | DIN 02475855 |
| EXTRA STRENGTH BISMUTH SUBSALICYLATE SUSPENSION | 35 MG | SUSPENSION | GUARDIAN DRUG COMPANY INC | MARKETED | DIN 02328453 |
| GASTROVOL LIQUID GELS | 262 MG | CAPSULE | CHURCH & DWIGHT CANADA CORP | MARKETED | DIN 02534436 |
| PEPTO BISMOL CAPLET - 262MG/CAPLET | 262 MG | TABLET | PROCTER & GAMBLE INC | MARKETED | DIN 02177994 |
| PEPTO BISMOL LIQUICAPS | 262 MG | CAPSULE | PROCTER & GAMBLE INC | MARKETED | DIN 02499991 |
| PEPTO-BISMOL | 17.6 MG | SUSPENSION | PROCTER & GAMBLE INC | MARKETED | DIN 02097079 |
| PEPTO-BISMOL EXTRA | 35.2 MG | SUSPENSION | PROCTER & GAMBLE INC | MARKETED | DIN 02229668 |
Who else supplies BISMUTH PREPARATIONS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BISMUTH PREPARATIONS appears in 13 registered pack listings across 6 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.